Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: a three-arm, double-blind, randomized clinical trial.

Background: Phytosterols and red yeast rice are largely studied cholesterol-lowering nutraceuticals, respectively inhibiting the bowel absorption and liver synthesis of cholesterol. Our aim was to test the effect on lipid profile of phytosterols, red yeast rice and their association. Methods: We per...

Descripción completa

Detalles Bibliográficos
Publicado en:Nutrition & Metabolism Vol. 14; pp. 1 - 8
Autores principales: Cicero, Arrigo F. G., Fogacci, Federica, Rosticci, Martina, Parini, Angelo, Giovannini, Marina, Veronesi, Maddalena, D'Addato, Sergio, Borghi, Claudio
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: BioMed Central 9/25/2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=125362055&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 125362055
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17437075
        1CYX
      jtl: Nutrition & Metabolism
      issn: 17437075
      maglogo: N
    pubinfo:
      dt: 9/25/2017
      vid: 14
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        125362055
        125362055
        125362055
        10.1186/s12986-017-0214-2
        125362055
      ppf: 1
      ppct: 7
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: a three-arm, double-blind, randomized clinical trial.
      aug:
        au:
          Cicero, Arrigo F. G.
          Fogacci, Federica
          Rosticci, Martina
          Parini, Angelo
          Giovannini, Marina
          Veronesi, Maddalena
          D'Addato, Sergio
          Borghi, Claudio
        affil: Medical and Surgical Sciences Department, University of Bologna, Via Albertoni 15, 40138 Bologna, Italy
      sug:
        subj:
          Hypercholesterolemia Therapy
          Phytosterols Therapeutic Use
          Red Yeast Rice
          Fermentation
          Dietary Supplements Therapeutic Use
          Human
          Randomized Controlled Trials
          Random Assignment
          Double-Blind Studies
          Cholesterol Blood
          Statistical Significance
          P-Value
          Lipoproteins, LDL Cholesterol Blood
          Descriptive Statistics
          Apolipoproteins Blood
          Drug Combinations Therapeutic Use
      ab: Background: Phytosterols and red yeast rice are largely studied cholesterol-lowering nutraceuticals, respectively inhibiting the bowel absorption and liver synthesis of cholesterol. Our aim was to test the effect on lipid profile of phytosterols, red yeast rice and their association. Methods: We performed a three parallel arms, double blind, clinical trial randomizing 90 moderately hypercholesterolemic subjects to treatment with phytosterols 800 mg (group 1), red yeast rice standardized to contain 5 mg monacolins from Monascus purpureus (group 2), or both combined nutraceuticals (group 3). Results: After 8 weeks of treatment, in group 1 no significant variation of lipid parameters has been detected. In group 2 a significant reduction (p < 0.001) of LDL-Cholesterol (-20.5% vs. baseline) and Apolipoprotein B (-14.4% vs. baseline) as it occurred in group 3 (LDL-Cholesterol vs. baseline: -27.0%, Apolipoprotein B vs. baseline: -19.0%) (P < 0.001). LDL-Cholesterol and Apolipoprotein B changes were significantly different comparing group 2 with group 1 (P < 0.05), and group 3 with group 1 (P < 0.05). LDL-Cholesterol change was also significantly higher in group 3 than in group 2 (P < 0.05). Conclusion: The association of phytosterol and red yeast rice seems to have additive cholesterol lowering effect, reaching a clinically significant LDL-Cholesterol reduction in mildly hypercholesterolemic patients. Trial registration: ClinicalTrial.gov ID: NCT02603276, Registered 27/08/2015.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N